SHREE GANESH REMEDIES
Back to Income Statement
|
SHREE GANESH REMEDIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Profit After Tax | ₹28 Cr | ₹1,047,056 Cr | ₹6.24 Cr | ₹6.24 Cr |
What is the latest Profit After Tax of SHREE GANESH REMEDIES ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹1,047,056 Cr |
| Mar2020 | ₹6.24 Cr |
| Mar2019 | ₹6.24 Cr |
How is Profit After Tax of SHREE GANESH REMEDIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹28 Cr | -100.00 | |
| Mar2024 | ₹1,047,056 Cr | 16,793,096.95 | |
| Mar2020 | ₹6.24 Cr | 0.00 | |
| Mar2019 | ₹6.24 Cr | - | |
Compare Profit After Tax of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹648.3 Cr | -1.9% | 25.7% | -34.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -1.9% |
25.7% |
-34.6% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses